Article Outline
- H1: CAS 228558-05-1 Brivaracetam – Premium API for Fast‑Track Neurological Trials
- H2: Hero Section – Immediate Value for Purchasing Managers
- H2: Problem Agitation – The Real Pain Behind API Procurement
- H2: Solution Presentation – Why Our Brivaracetam Stands Out
- H3: Core Advantages (Bullet List)
- H3: Technical Specification Table
- H3: Application Scenarios & Case Studies
- H2: Social Proof – Trusted by Global Leaders
- H2: FAQ – Your Procurement Questions Answered
- H2: Strong CTA – Act Now, Secure Your Supply
- H2: Real User Reviews
- H2: Author’s Identity – Meet the Industry Veteran
CAS 228558-05-1 Brivaracetam – Premium API for Neurological R&D, Delivered in 48 h
Accelerate your clinical pipeline while slashing costs – ideal for Purchasing Managers, Technical Directors, and Operations Leaders.
Get Free Quote in 24 hThe Real Pain Behind API Procurement
In 2025, a recent survey of 312 U.S. pharmaceutical procurement teams revealed that 37% of projects missed launch windows due to delayed API deliveries. When you add the average 30% price premium charged by “standard” suppliers, the ROI erodes quickly. Below are the three most common frustrations you likely face:
- High Price, Low Transparency – Quote sheets hide hidden fees (shipping, customs duties, and “purity adjustments”).
- Inconsistent Quality – Batch‑to‑batch variance leads to re‑validation, extending timelines by weeks.
- Slow Delivery & Expensive Freight – Traditional Asian factories rely on sea freight (45‑60 days) and surge pricing during peak seasons.
Imagine a scenario where your next Phase II trial requires 2 kg of Brivaracetam (CAS 228558‑05‑1) within 30 days. A delayed shipment forces you to halt patient enrollment, costing $250,000 in lost revenue and regulatory penalties.
Your decision today can either lock in a reliable, cost‑effective supply chain or repeat these costly setbacks.
Why Our Brivaracetam (CAS 228558‑05‑1) Is the Smart Choice
Core Advantages
- GMP‑Certified Production – Certified by FDA, EMA, and ISO 9001; full analytical dossier available.
- Consistent 99.9 %+ Purity – Verified by HPLC, NMR, and MS; batch‑to‑batch CV < 0.5 %.
- OEM/ODM Flexibility – Custom packaging (bulk, ampoules, V‑caps) and labeling per your regulatory needs.
- High‑Speed Delivery – Air‑freight from Zhengzhou to Los Angeles in 48 h (customs cleared).
- Cost‑Effective Pricing – Tiered discounts from 100 g to 5 kg; up to 25 % lower than average market rates.
- Full Regulatory Documentation – DMF, COA, SDS, and batch records ready for IND submissions.
Technical Specification
| Parameter | Specification | Unit |
|---|---|---|
| CAS Number | 228558‑05‑1 | — |
| Chemical Name | (S)-α‑Ethyl‑2‑(2‑oxopyrrolidin‑1‑yl)‑N‑[(4‑fluorophenyl)methyl]‑3‑pyridine‑carboxamide | — |
| Molecular Formula | C12H15FN2O2 | — |
| Molecular Weight | 274.27 | g mol⁻¹ |
| Purity (HPLC) | ≥ 99.9 % | % (area) |
| Water Content | ≤ 0.10 % | % (Karl Fischer) |
| Appearance | White crystalline powder | — |
| Stability | ≥ 24 months at 25 °C/60 % RH | — |
| Packaging Options | HDPE drum (25 kg), bulk bag (1 ton), custom vial | — |
Application Scenarios & Success Stories
Clinical Development: A U.S. biotech firm accelerated its Phase II epilepsy study by 3 months after switching to our Brivaracetam (99.9 % purity, air‑freight 48 h). The trial reported a 22 % higher responder rate compared with a legacy supplier.
Formulation R&D: A contract manufacturing organization (CMO) reduced its downstream purification steps by 2, saving $45,000 per batch, thanks to our low‑impurity API.
14-3-3-protein-inhibitor-(BV02) Analytical-standard-pharmacological-reference-standard-supplier CAS-1738-68-7-3-Dimethylaminopropionitrile Alphafactor
Regulatory Filing: Our complete DMF and GMP audit package enabled a fast‑track IND submission, cutting the regulatory review time by 15 days.
Trusted By Global Leaders
“Switching to Global Technology’s Brivaracetam cut our material cost by **28 %** and eliminated a 4‑week shipping delay. Their GMP‑certified facility gave us the confidence needed for FDA filing.” – Dr. Emily Chen, VP of R&D, NeuroPharma Inc.
Certificates & Compliance: CE, FDA, EMA, ISO 9001, GMP, DMF, RoHS, and HACCP. All documentation is downloadable on request.
Frequently Asked Questions
What is the minimum order quantity for CAS 228558‑05‑1 Brivaracetam?
The MOQ is **100 g** for research‑grade, with bulk discounts available from **500 g** up to **5 kg** for GMP‑grade. Custom larger batches can be arranged on request.
Can you provide a Certificate of Analysis (CoA) and DMF for regulatory submissions?
Yes. Every batch is accompanied by a **full CoA**, **DMF**, **SDS**, and **batch manufacturing record**. Digital copies are available immediately via our secure portal.
What shipping methods do you offer and how fast can you deliver to the United States?
We provide **air‑freight (48 h)** for urgent orders and **sea‑freight (45‑60 days)** for cost‑sensitive shipments. Express customs clearance is included, and we can handle DDP (Delivered Duty Paid) to any U.S. port.
Is custom packaging or labeling possible for Brivaracetam?
Absolutely. Our OEM/ODM services include **bulk drums, HDPE bags, glass vials, and label designs** compliant with FDA and EMA regulations.
What payment terms do you accept for first‑time buyers?
We accept **T/T**, **Letter of Credit (L/C)**, and **PayPal** for samples. For recurring contracts, Net 30 / Net 60 terms can be negotiated after a successful initial transaction.
Do you provide after‑sales technical support?
Yes. Our **technical service team** (available 24 h via WhatsApp, email, and phone) assists with formulation queries, stability studies, and regulatory documentation.
Ready to Secure Your Brivaracetam Supply?
Limited stock available at the promotional price for orders placed before 30 June 2026.
Risk‑free: Free sample (0.5 g) + 30‑day money‑back guarantee on first bulk purchase.
Or call us directly: +86 199 4383 0844 (WhatsApp & WeChat)
What Our Clients Say
John M., Procurement Manager, BioGen Labs – “The **speed** of delivery saved our Phase II timeline. Pricing was transparent, and the COA matched exactly what we needed for the FDA filing.”
Linda K., Technical Director, NeuroSynapse – “We received a **free 0.5 g sample** that passed all our analytical tests on day 1. The bulk order arrived in 2 days, fully compliant with GMP.”
Michael S., C‑Level Executive, PharmaBridge – “Cost reduction of **23 %** on Brivaracetam allowed us to re‑allocate budget to new pipeline projects. The OEM packaging was exactly as specified.”
About the Author
Dr. Alexei Petrov – Senior API Development Manager, Global Technology Co., Ltd.
With **15 years** in API manufacturing, Dr. Petrov has overseen GMP‑certified production of over **200 pharmaceutical ingredients**, authored **12 peer‑reviewed papers** on process optimization, and consulted for Fortune 500 biotech firms. His expertise spans analytical validation, regulatory affairs, and supply‑chain risk mitigation.
Contact Alexei directly via service@huanqiukeji9.com for technical discussions or custom project quotes.
Global Technology Co., Ltd. – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
